Oncología médica
Especialidad
Mutua de Terrassa
Terrassa, EspañaPublications en collaboration avec des chercheurs de Mutua de Terrassa (6)
2014
-
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer
Oncology Research, Vol. 21, Núm. 4, pp. 181-191
-
Prognostic factors for relapse in stage I seminoma: A new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
Annals of Oncology, Vol. 25, Núm. 11, pp. 2173-2178
2013
2011
-
Risk-adapted treatment in clinical stage I testicular seminoma: The third Spanish Germ Cell Cancer Group study
Journal of Clinical Oncology, Vol. 29, Núm. 35, pp. 4677-4681
2009
-
Screening for epidermal growth factor receptor mutations in lung cancer
New England Journal of Medicine, Vol. 361, Núm. 10, pp. 958-967
2008
-
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer
Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814